Two distinct themes emerge from a cursory glance at the rich list: Digital and health
Ajay Singh belongs to a rare breed that revels in the Herculean odds of turning around an airline
Dr Reddy's Laboratories, risk-taker and pioneer of several new drugs and R&D has its reasons for partnering with Russia, which go way beyond the vaccine.
Infosys's performance is a sign of the resilience of its strategy and operating model
In April-June, Britannia's net profits were up by 118% over a year ago, and at a three-year high
If there are glimmers of hope for the economy, they're largely being seen in agrarian India
Digital-first brands have the capacity to disrupt their brick-and-mortar counterparts
If shattering of gender stereotypes needed a shot in the arm, it came during the lockdowns
The pandemic may have deepened the chasm between the have-much and the have-little
A pivot during Covid-19 could well start out as survival gambit but end up as a huge opportunity